Identification and characterization of a ligand-selective mineralocorticoid receptor coactivator

FASEB Journal

Volumn 28, Issue 10, 2014, Pages 4200-4210

  Rogerson, Fraser M ^a,b   Yao, Yi Zhou ^a   Young, Morag J ^a   Fuller, Peter J ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b RMIT UNIVERSITY   (Australia)

Author keywords

Aldosterone; Cortisol; Nuclear receptors

Indexed keywords

ALDOSTERONE; HYDROCORTISONE; MINERALOCORTICOID RECEPTOR; METALLOTHIONEIN; NUCLEAR RECEPTOR COACTIVATOR; PROTEIN BINDING; TESMIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; DNA LIBRARY; HUMAN; HUMAN TISSUE; LIGAND BINDING; LIGAND BINDING DOMAIN; NUCLEOTIDE SEQUENCE; PROTEIN CONFORMATION; TRANSACTIVATION; ANIMAL; BINDING SITE; CHEMISTRY; CHLOROCEBUS AETHIOPS; COS 1 CELL LINE; ENZYME SPECIFICITY; GENETICS; METABOLISM; PROMOTER REGION; TWO HYBRID SYSTEM;

ALDOSTERONE; ANIMALS; BINDING SITES; CERCOPITHECUS AETHIOPS; COS CELLS; HUMANS; HYDROCORTISONE; METALLOTHIONEIN; NUCLEAR RECEPTOR COACTIVATORS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RECEPTORS, MINERALOCORTICOID; SUBSTRATE SPECIFICITY; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 84907709951     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.13-242479     Document Type: Article

References (61)

1. Fuller, P. J., and Young, M. J. (2005) Mechanisms of mineralocorticoid action. Hypertension 46, 1227-1235
2. Cachofeiro, V., Miana, M., de Las Heras, N., Martin-Fernandez, B., Ballesteros, S., Fernandez-Tresguerres, J., and Lahera, V. (2008) Aldosterone and the vascular system. J. Steroid Biochem. Mol. Biol. 109, 331-335
3. Joels, M., Karst, H., DeRijk, R., and de Kloet, E. R. (2008) The coming out of the brain mineralocorticoid receptor. Trends Neurosci. 31, 1-7
4. Armstrong, P. W. (2004) Aldosterone antagonists: last man standing? N. Engl. J. Med. 364, 79-80
5. Pitt, B., Reichek, N., Willenbrock, R., Zannad, F., Phillips, R. A., Roniker, B., Kleiman, J., Krause, S., Burns, D., and Williams, G. H. (2003) Effects of eplerenone, enalapril and eplerenone/ enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study. Circulation 108, 1831-1838
6. Juurlink, D. N., Mamdani, M. M., Lee, D. S., Kopp, A., Austin, P. C., Laupacis, A., and Redelmeier, D. A. (2004) Rates of hyperkalemia after publication of the randomized aldactone evaluation study. N. Engl. J. Med. 351, 543-551
7. Gronemeyer, H., Gustafsson, J. Å., and Laudet, V. (2004) Principles for modulation of the nuclear receptor superfamily. Nat. Rev. 3, 950-964
8. Lu, N. Z., Wardell, S. E., Burnstein, K. L., Defranco, D., Fuller, P. J., Giguere, V., Hochberg, R. B., McKay, L., Renoir, J. M., Weigel, N. L., Wilson, E. M., McDonnell, D. P., and Cidlowski, J. A. (2006) International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors. Pharmacol. Rev. 58, 782-797
9. Glass, C. K., and Rosenfeld, M. G. (2000) The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14, 121-141
10. Ding, X. F., Anderson, C. M., Ma, H., Hong, H., Uht, R. M., Kushner, P. J., and Stallcup, M. R. (1998) Nuclear receptorbinding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities. Mol. Endocrinol. 12, 302-313
11. Zennaro, M.-C., Souque, A., Viengchareun, S., Poisson, E., and Lombès, M. (2001) A new human MR splice variant is a ligand-independent transactivator modulating corticosteroid action. Mol. Endocrinol. 15, 1586-1598
12. Meijer, O. C., Kalkhoven, E., van der Laan, S., Steenbergen, P. J., Houtman, S. H., Dijkmans, T. F., Pearce, D., and de Kloet, E. R. (2005) Steroid receptor coactivator-1 splice variants differentially affect corticosteroid receptor signaling. Endocrinology 146, 1438-1448
13. Weiss, R. E., Gehin, M., Xu, J. M., Sadow, P. M., O'Malley, B. W., Chambon, P., and Refetoff, S. (2002) Thyroid function in mice with compound heterozygous and homozygous disruptions of SRC-1 and TIF-2 coactivators: evidence for haploinsufficiency. Endocrinology 143, 1554-1557
14. Xu, J. M., Liao, L., Ning, C., Yoshida-Komiya, H., Deng, C. X., and O'Malley, B. W. (2000) The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proc. Natl. Acad. Sci. U.S.A. 97, 6379-6384
15. Berger, S., Bleich, M., Schmid, W., Cole, T. J., Peters, J., Watanabe, H., Kriz, W., Warth, R., Greger, R., and Schultz, G. (1998) Mineralocorticoid receptor knockout mice: pathophysiology of Na+ metabolism. Proc. Natl. Acad. Sci. U.S.A. 95, 9424-9429
16. Knutti, D., and Kralli, A. (2001) PGC-1, a versatile coactivator. Trends Endocrinol. Metab. 12, 360-365
17. Portilla, D., Dai, G., McClure, T., Bates, L., Kurten, R., Megyesi, J., Price, P., and Li, S. Y. (2002) Alterations of PPAR alpha and its coactivator PGC-1 in cisplatin-induced acute renal failure. Kidney Int. 62, 1208-1218
18. Smith, C. L., and O'Malley, B. W. (2003) Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr. Rev. 25, 45-71
19. O'Malley, B. W., and McKenna, N. J. (2008) Coactivators and corepressors: what's in a name? Mol. Endocrinol. 22, 2213-2214
20. Fuse, H., Kitagawa, H., and Kato, S. (2000) Characterization of transactivational property and coactivator mediation of rat mineralocorticoid receptor activation function-1 (AF-1). Mol. Endocrinol. 14, 889-899
21. Viengchareun, S., LeMenuet, D., Martinerie, L., Munier, M., Pascual-Le Tallec, L., and Lombès, M. (2007) The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology. Nucl. Recept. Signal. 5, 1-16
22. Pascual-Le Tallec, L., Kirsh, O., Lecomte, M. C., Viengchareun, S., Zennaro, M. C., Dejean, A., and Lombes, M. (2003) Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification. Mol. Endocrinol. 17, 2529-2542
23. Obradović, D., Tirard, M., Nèmethy, Z., Gronemeyer, H., and Almeida, O. F. X. (2004) DAXX, FLASH, and FAF-1 modulate mineralocorticoid and glucocorticoid receptor-mediated transcription in hippocampal cells: toward a basis for the opposite actions elicited by two nuclear receptors? Mol. Pharmacol. 65, 761-769
24. Pascual-Le Tallec, L., Simone, F., Viengchareun, S., Meduri, G., Thirman, M. J., and Lombès, M. (2005) The elongation factor ELL (eleven-nineteen lysine-rich leukemia) is a selective coregulator for steroid receptor functions. Mol. Endocrinol. 19, 1158-1169
25. Yokota, K., Shibata, H., Kurihara, I., Kobayashi, S., Suda, N., Murai-Takeda, A., Saito, I., Kitagawa, H., Kato, S., Saruta, T., and Itoh, H. (2007) Coactivation of the N-terminal transactivation of mineralocorticoid receptor by Ubc9. J. Biol. Chem. 282, 1998-2010
26. Murai-Takeda, A., Shibata, H., Kurihara, I., Kobayashi, S., Yokota, K., Suda, N., Mitsuishi, Y., Jo, R., Kitagawa, H., Kato, S., Saruta, T., and Itoh, H. (2010) NF-YC functions as a corepressor of agonist-bound mineralocorticoid receptor. J. Biol. Chem. 285, 8084-8093
27. Kitagawa, H., Yanagisawa, J., Fuse, H., Ogawa, S., Yogiashi, Y., Okuno, A., Nagasawa, H., Nakajima, T., Matsumoto, T., and Kato, S. (2002) Ligand-selective potentiation of rat mineralocorticoid receptor activation function 1 by a CBP-containing histone acetyltransferase complex. [Retraction (2014) Mol. Cell. Biol. 34, 916] Mol. Cell. Biol. 22, 3698-3706
28. Hultman, M. L., Krasnoperova, N. V., Li, S., Du, S., Xia, C., Dietz, J. D., Lala, D. S., Welsch, D. J., and Hu, X. (2004) The ligand-dependent interaction of mineralocorticoid receptor with coactivator and corepressor peptides suggests multiple activation mechanisms. Mol. Endocrinol. 19, 1460-1473
29. Li, Y., Suino, K., Daugherty, J., and Xu, H. E. (2005) Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor. Mol. Cell 19, 367-380
30. White, P. C., Mune, T., and Agarwal, A. K. (1997) 11 beta- Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr. Rev. 18, 135-156
31. Gomez-Sanchez, E. P., Venkataraman, M. T., Thwaites, D., and Fort, C. (1990) ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension. Am. J. Physiol. 258, E649-E653
32. Sato, A., and Funder, J. W. (1996) High glucose stimulates aldosterone-induced hypertrophy via type 1 mineralocorticoid receptors in neonatal rat cardiomyocytes. Endocrinology 137, 4145-4153
33. Mihailidou, A. S. (2006) Nongenomic actions of aldosterone: physiological or pathophysiological role? Steroids 71, 277-280
34. Rogerson, F. M., and Fuller, P. J. (2003) Interdomain interactions in the mineralocorticoid receptor. Mol. Cell. Endocrinol. 200, 45-55
35. Pippal, J. B., Yao, Y., Rogerson, F. M., and Fuller, P. J. (2009) Structural and functional characterisation of the interdomain interaction in the mineralocorticoid receptor. Mol. Endocrinol. 23, 1360-1370
36. Rogerson, F. M., Dimopoulos, N., Sluka, P., Chu, S., Curtis, A. J., and Fuller, P. J. (1999) Structural determinants of aldosterone binding selectivity in the mineralocorticoid receptor. J. Biol. Chem. 274, 36305-36311
37. Rogerson, F. M., Yao, Y., Elsass, R. E., Dimopoulos, N., Smith, B. J., and Fuller, P. J. (2007) A critical region in the mineralocorticoid receptor for aldosterone binding and activation by cortisol: evidence for a common mechanism governing ligand binding specificity in steroid hormone receptors. Mol. Endocrinol. 21, 817-828
38. Savkur, R. S., and Burris, T. P. (2004) The coactivator LxxLL nuclear receptor recognition motif. J. Pept. Res. 63, 207-212
39. Yang, J., Chang, C.-Y., Safi, R., Morgan, J., McDonnell, D. P., Fuller, P. J., Clyne, C. D., and Young, M. J. (2011) Identification of ligand-selective peptide antagonists of the mineralocorticoid receptor using phage display. Mol. Endocrinol. 25, 32-43
40. Ziera, T., Irlbacher, H., Fromm, A., Latouche, C., Krug, S. M., Fromm, M., Jaisser, F., and Borden, S. A. (2009) Cnksr3 is a direct mineralocorticoid receptor target gene and plays a key role in the regulation of the epithelial sodium channel. FASEB J. 23, 3936-3946
41. Jiang, P., Hu, Q., Ito, M., Meyer, S., Waltz, S., Khan, S., Roeder, R. G., and Zhang, X. (2010) Key roles for MED1 LxxLL motifs in pubertal mammary gland development and luminal-cell differentiation. Proc. Natl. Acad. Sci. U.S.A. 107, 6765-6770
42. Wright, A. P., and Gustafsson, J. A. (1992) Glucocorticoidspecific gene activation by the intact human glucocorticoids receptor expressed in yeast: glucocorticoid specificity depends on low level receptor expression. J. Biol. Chem. 267, 11191-11195
43. Kralli, A., and Yamamoto, K. R. (1996) An FK506-sensitive transporter selectively decreases intracellular levels and potency of steroid hormones. J. Biol. Chem. 271, 17152-17156
44. Sugihara, T., Wadhwa, R., Kaul, S. C., and Mitsui, Y. (1999) A novel testis-specific metallothionein-like protein, tesmin, is an early marker of male germ cell differentiation. Genomics 57, 130-136
45. Nordeen, S. K., Bona, B. J., Beck, C. A., Edwards, D. P., Borror, K. C., and DeFranco, D. B. (1995) The two faces of a steroid antagonist: when an antagonist isn't. Steroids 60, 97-104
46. Massaad, C., Lombès, M., Aggerbeck, M., Rafestin-Oblin, M. E., and Barouki, R. (1997) Cell-specific promoter-dependent mineralocorticoid agonist activity of spironolactone. Mol. Pharmacol. 51, 285-292
47. Beato, M. (1991) Transcriptional control by nuclear receptors. FASEB J. 5, 2044-2051
48. Lopez, F. J., Ardecky, R. J., Bebo, B., Benbatoul, K., De Grandpre, L., Liu, S., Leibowitz, M. D., Marschke, K., Rosen, J., Rungta, D., Viveros, H. O., Yen, W. C., Zhi, L., Negro-Villar, A., and Miner, J. N. (2008) LGD-5552, an antiinflammatory glucocorticoid receptor ligand with reduced side effects, in vivo. Endocrinology 149, 2080-2089
49. Miner, J. N., Chang, W., Chapman, M. S., Finn, P. D., Hong, M. H., Lopez, F. J., Marschke, K. B., Rosen, J., Schrader, W., Turner, R., van Oeveren, A., Viveros, H., Zhi, L., and Negro- Vilar, A. (2007) An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate. Endocrinology 148, 363-373
50. Sasaki, H., Ohara, N., Xu, Q., Wang, J., DeManno, D. A., Chwalisz, K., Yoshida, S., and Maruo, T. (2006) A novel selective progesterone receptor modulator asoprisnil activates tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated signaling pathway in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells. J. Clin. Endocrinol. Metab. 92, 616-623
51. Bledsoe, R. K., Madauss, K. P., Holt, J. A., Apolito, C. J., Lambert, M. H., Pearce, K. H., Stanley, T. B., Stewart, E. L., Trump, R. P., Willson, T. M., and Williams, S. P. (2005) A ligand-mediated hydrogen bond network required for the activation of the mineralocorticoid receptor. J. Biol. Chem. 280, 31283-31293
52. Anderson, S. U., Algreen-Petersen, R. G., Hoedl, M., Jurkiewicz, A., Cvitanich, C., Braunschweig, U., Schauser, L., Oh, S. A., Twell, D., and Jensen, E.Ø. (2007) The conserved cysteine-rich domain of a tesmin/TSO1-like protein binds zinc in vitro and TSO1 is required for both male and female fertility in Arabidopsis thaliana. J Exp. Bot. 58, 3657-3670
53. Olesen, C., Møller, M., and Byskov, A. G. (2004) Tesmin transcription is regulated differently during male and female meiosis. Mol. Reprod. Dev. 67, 116-126
54. Oh, J. H., Yang, J. O., Hahn, Y., Kim, M. R., Byun, S. S., Jeon, Y. J., Kim, J. M., Song, K. S., Noh, S. M., Kim, S., Yoo, H. S., Kim, Y. S., and Kim, N. S. (2005) Transcriptome analysis of human gastric cancer. Mamm. Genome 16, 942-954
55. Sutou, S., Miwa, K., Matsuura, T., Kawasaki, Y., Ohinata, Y., and Mitsui, Y. (2003) Native tesmin is a 60-kilodalton protein that undergoes dynamic changes in its localization during spermatogenesis in mice. Biol. Reprod. 68, 1861-1869
56. Matsuura, T., Kawasaki, Y., Miwa, K., Sutou, S., Ohinata, Y., Yoshida, F., and Mitsui, Y. (2002) Germ cell-specific nucleocytoplasmic shuttling protein, tesmin, responsive to heavy metal stress in mouse testes. J. Inorg. Biochem. 88, 183-191
57. Khanna, S., Lakhera, P. C., and Khandelwal, S. (2011) Interplay of early biochemical manifestations by cadmium insult in sertoligerm coculture: an in vitro study. Toxicology 287, 46-53
58. Young, M. J. (2008) Mechanisms of mineralocorticoid receptormediated cardiac fibrosis and vascular inflammation. Curr. Opin. Nephrol. Hypertens. 17, 174-180
59. Thomas, M., Vidal, A., Bhattacharya, S. K., Ahokas, R. A., Sun, Y., Gerling, I. C., and Weber, K. T. (2007) Zinc dyshomeostasis in rats with aldosteronism: response to spironolactone. Am. J. Physiol. Heart Circ. Physiol. 293, H2361-H2363
60. Fagart, J., Huyet, J., Pinon, G. M., Rochel, M., Mayer, C., and Rafestin-Oblin, M. E. (2005) Crystal structure of a mutant mineralocorticoid receptor responsible for hypertension. Nat. Struct. Mol. Biol. 12, 554-555
61. Chang, C. Y., Abdo, J., Hartney, T., and McDonnell, D. P. (2005) Development of peptide antagonists for the androgen receptor using combinatorial peptide phage display. Mol. Endocrinol. 19, 2478-2499